PROFILE OF BPH PATIENTS UNDERGOING TURP AT JASA KARTINI HOSPITAL TASIKMALAYA FROM 2021 TO 2023
##plugins.themes.bootstrap3.article.main##
##plugins.themes.bootstrap3.article.sidebar##
Abstract
Introduction: Transurethral Resection of Prostate (TURP) has become the most frequently recommended minimally invasive procedure for patients with LUTS caused by BPH. BPH being the most common cause of LUTS in men and TURP being the most commonly recommended procedure in its management. Objective: This study aims to provide the profile of BPH patients undergoing TURP procedures at Jasa Kartini Hospital, Tasikmalaya, from January 2021 to September 2023. Material & Methods: This study is a descriptive cross-sectional conducted using consecutive sampling method. Results: During the period of January 2021 to September 2023, there were 214 BPH patients who underwent TURP procedures and this number had increasing trend each year. The prevalence of BPH patients undergoing TURP procedures was highest in the age group of 60-69 years (37.38%). 52.34% of patients resided in Tasikmalaya Regency. The most common comorbidities were hypertension (71.03%), vesicolithiasis (14.95%), and fatty liver (10.28%). Among BPH patients undergoing TURP procedures, 59.35% had prostate volumes ranging from 30 to 80ml. TURP procedures in this study lasted ≤ 60 minutes in 80.84% of cases and 73.83% had a hospital stay of 3 days. The majority of BPH patients undergoing TURP with prostate volumes of 30-80 ml were in the aged group of 60-69 years, while those with prostate volumes >80 ml were mostly aged 70-79 years. Conclusion: The prevalence of BPH patients undergoing TURP procedures from January 2021 to September 2023 at Jasa Kartini Hospital Tasikmalaya was 214 patients, with the highest prevalence observed in the age group of 60-69 years. The majority of BPH patients undergoing TURP procedures had prostate volumes ranging from 30 to 80 ml and underwent procedures lasting ≤ 60 minutes. Keywords: TURP, BPH, LUTS.
##plugins.themes.bootstrap3.article.details##
TURP, LUTS, BPH
Cornu JN, Gacci M, Hashim M, et al. EAU Guidelines on Non-Neurogenic Male Lower Urinary Tract Symptoms (LUTS), incl. Benign Prostatic Obstruction (BPO). 2023.
Karavitakis M, Kyriazis I, Omar MI, et al. Management of Urinary Retention in Patients with Benign Prostatic Obstruction: A Systematic Review and Meta-analysis. Eur Urol. 2019 May 1;75:788–98.
Billet M, Windsor TA. Urinary Retention. Vol. 37, Emergency Medicine Clinics of North America. W.B. Saunders; 2019. p. 649–60.
Sari ERLN, Siswandi A, Anggunan. Hubungan Usia Dan Hipertensi Terhadap Kejadian Bph Di Rsud Dr.H.Abdul.Moeloek. Malahayati Health Student Journal. 2021;1(3):247–51.
Awedew AF, Han H, Abbasi B, et al. The Global, Regional, And National Burden Of Benign Prostatic Hyperplasia In 204 Countries And Territories From 2000 To 2019: A Systematic Analysis For The Global Burden of Disease Study 2019. Lancet Healthy Longev. 2022 Nov 1;3(11):e754–76.
Tjahjodjati, Soebadi DM, Umbas R, et al. Panduan Penatalaksanaan Klinis Pembesaran Prostat Jinak. 4th ed. Ikatan Ahli Urologi Indonesia (IAUI); 2021.
Prasetyo ZA, Budaya TN, Daryanto B. Characteristics of Benign Prostatic Hyperplasia (BPH) Patients Undergoing Transurethral Resection of the Prostate (TURP). Jurnal Kedokteran Brawijaya. 2021 Aug 31;31(4):220–3.
Eredics K, Wachabauer D, Röthlin F, et al. Reoperation Rates and Mortality After Transurethral and Open Prostatectomy in a Long-term Nationwide Analysis: Have We Improved Over a Decade? Urology. 2018 Aug 1;118:152–7.
Daryanto B, Wahyudi I, Hamid ARAH. Rekomendasi Pelayanan Urologi terkait COVID-19. 1st ed. Ikatan Ahli Urologi Indonesia (IAUI); 2020.
Aboumarzouk OM. Blandy’s Urology. Vol. 3. Oxford; 2019.
Partin AW, Kavoussi LR, Peters CA. Campbell-Walsh-Wein Handbook of Urology. 2022.
Gupta Wijaya A, Sadra Telussa A. Relationship Between Hypertension And Diabetes Mellitus Type 2 With Benign Prostate Hyperplasia In Mgr. Gabriel Manek Hospital ATAMBUA. Cendana Medical Journal, Edisi. 2021;22(2).
Jung JH, Park J, Kim WT, et al. The association of benign prostatic hyperplasia with lower urinary tract stones in adult men: A retrospective multicenter study. Asian J Urol. 2018 Apr 1;5(2):118–21.
Huang W, Cao JJ, Cao M, et al. Risk factors for bladder calculi in patients with benign prostatic hyperplasia. Medicine (United States). 2017 Aug 1;96(32).
Lu CH, Wu HHH, Lin TP, et al. Is intravesical prostatic protrusion a risk factor for hydronephrosis and renal insufficiency in benign prostate hyperplasia patients? Journal of the Chinese Medical Association. 2019 May 1;82:381–4.
Speakman MJ, Cheng X. Management of the complications of BPH/BOO. Indian Journal of Urology. 2014;30(2):208–13.
Chung GE, Yim JY, Kim D, et al. Nonalcoholic Fatty Liver Disease Is Associated with Benign Prostate Hyperplasia. J Korean Med Sci. 2020 Jun 8;35(22).
Kopp W. Diet-Induced Hyperinsulinemia as a Key Factor in the Etiology of Both Benign Prostatic Hyperplasia and Essential Hypertension? Nutr Metab Insights. 2018 May 6;11:1–11.
Meng J, Liu Y, Guan SY, et al. Age, height, BMI and FBG predict prostate volume in ageing benign prostatic hyperplasia: Evidence from 5285 patients. Int J Clin Pract. 2019 Dec 1;73(12).
Nadilla S, Sangadji AASC. Karakteristik Pasien Benign Prostatic Hyperplasia (BPH) Berdasarkan Transabdominal Ultrasonography (TAUS) di RSU Al-Fatah Ambon Periode 2019-2021. Jurnal Kesehatan Tambusai. 2023;4(4).
Bhatta P, Raya A, Yadav UK, et al. Median Duration Of Hospital Stay After Early Removal Of Foley’s Catheter Among Patients Undergoing Transurethral Resection Of Prostate: A descriptive cross-sectional study. Journal of the Nepal Medical Association. 2021 Jul 1;59(239):688–91.
Sagen E, Javid R, Liivrand L, et al. Patient Related Factors Affecting In-Hospital Costs of a TURP Procedure. Scand J Urol. 2021;55(4):324–30.
Mulyadi HTS, Sugiarto. Prevalensi Hiperplasia Prostat dan Adenokarsinoma Prostat secara Histopatologi di Laboratorium Patologi Anatomi Rumah Sakit Umum Daerah Cibinong. Muhammadiyah Journal of Geriatric. 2020;1(1).
Sakamoto H, Matsumoto K, Hayakawa N, et al. Preoperative parameters to predict incidental (T1a and T1b) prostate cancer. Canadian Urological Association Journal. 2014 Nov 1;8(11–12):e815–20.